Table 1.

Characteristics of de novo DLBCL patients in the NCCN and BCCA cohorts

Cohort characteristics	NCCN (n = 1650)	BCCA (n = 1138)
Male gender	54%	60%
Age (y), mean (SD)	57 (16)	63 (15)
Age >60 y, %	46%	60%
LDH ratio >1, %	50%	49%
Ann Arbor stage (III-IV), %	59%	55%
ECOG PS (≥2), %	11%	37%
Extranodal disease,* %	36%	25%

^*Lymphomatous involvement in the bone marrow, CNS, liver/GI tract, or lung.